The DISSOLVE I and II trials evaluated the efficacy and safety of 2 different dose levels of SEL-212 in adults 19 years of age and older with chronic refractory gout.

Low-dose tamoxifen reduces the risk of breast cancer among patients with intraepithelial neoplasia for several years, data suggest.

Net monetary benefit from group B Streptococcus vaccination estimated to range from $1.1 to $17 billion

Patients switching from efavirenz to dolutegravir gain more weight at 12 months and have increased risk for hypertension.

Prevalence of pregnancy and incidence of conception were lower for phentermine-topiramate vs topiramate and other antiobesity meds.

The approval of the new citrate-free, high-concentration formulation was based on data from a phase 1 pharmacokinetics bridging study.

Inspire therapy is a fully implanted neurostimulation device that consists of a small generator, a sensing lead, and a stimulation lead.

Percentage increase in clinical cases in US grew each year from 44% increase in 2019 to 95% increase in 2021

Ulenistamab targets pancreatic adenocarcinoma upregulated factor, a tumor-specific protein.

Adding vistusertib to treatment with paclitaxel does not improve outcomes in patients with platinum-resistant or -refractory ovarian cancer, a phase 2 trial suggests.